FDA Import Refusal AEK-7752157-1/10003/1 — CIPLA LTD
The FDA refused shipment AEK-7752157-1/10003/1 from CIPLA LTD (India) on Oct 14, 2025. The refused product falls under Drugs and Biologics — LOVASTATIN (ANTI-CHOLESTEREMIC). Cited charges: 118,3280 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Oct 14, 2025
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61JDY12 LOVASTATIN (ANTI-CHOLESTEREMIC)
- Charges
- 118,3280